Semax and Selank are short, intranasal neuropeptides that came out of Russia’s peptide-drug program and the Institute of Molecular Genetics (RAS). Both are registered medicines in the Russian Federation (Semax classified as a nootropic; Selank as an anxiolytic), with decades of lab and clinical use there—yet very different “feels” when you actually use them. […]
Semax is a synthetic peptide developed in Russia in the 1980s as a nootropic and neuroprotective agent. Unlike many cognitive enhancers, Semax has been used as a registered pharmaceutical in Russia and CIS countries for decades, where it is prescribed for conditions such as stroke recovery, traumatic brain injury, cognitive decline, and optic nerve disease. What […]
Retatrutide Side Effects: What Clinical Trials Reveal Retatrutide is a next-generation triple agonist, designed to stimulate the GLP-1, GIP, and glucagon receptors simultaneously. Early studies show remarkable results, with participants losing as much as 24% of their body weight in less than a year when given the highest doses (Jastreboff, New England Journal of Medicine). […]
Retatrutide Half-Life: What It Means for Dosing and Effectiveness Retatrutide is a next-generation triple agonist that targets the GLP-1, GIP, and glucagon receptors simultaneously. This unique mechanism has delivered some of the most dramatic results ever seen in obesity treatment, with participants in Phase 2 trials losing up to 24% of their body weight in […]
When it comes to post-cycle therapy (PCT), controlling estrogen is one of the most critical factors for restoring natural testosterone production, preventing gynecomastia, and protecting long-term hormonal health. While pharmaceutical SERMs like tamoxifen and clomiphene are widely used, they can bring harsh side effects and are not always the best option for long-term balance. That’s […]